Description
Concentration – 5 mg per vial
Physical Form – Lyophilized powder (sterile 3 mL vial)
Product Features
-
Freeze-dried for maximal shelf stability
-
Butyl rubber stopper allows multiple punctures while maintaining a secure seal
-
Vials are depyrogenated, ETO-sterilized, and finished with a tamper-evident aluminum flip-top
Research Highlights
-
Triple Agonist Mechanism: Retatrutide is an experimental peptide that activates GLP-1, GIP, and glucagon receptors, showing synergistic metabolic benefits in preclinical studies.
-
Weight Management: Animal models demonstrate substantial body weight reductions, improved insulin sensitivity, and enhanced lipid profiles.
-
Glycemic Control: Dual incretin and glucagon receptor stimulation promotes glucose lowering while preserving lean muscle mass.
-
Metabolic Flexibility: Studies suggest improvements in mitochondrial function, fatty acid oxidation, and energy expenditure.
-
Emerging Applications: Being investigated for potential roles in obesity, type 2 diabetes, and cardiometabolic disease prevention.

Reviews
There are no reviews yet.